Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (29)
  • 2024 (14)
  • 2023 (20)
  • 2022 (35)
  • 2021 (17)
  • 2020 (7)
  • 2019 (16)
  • 2018 (24)
  • 2017 (19)
  • 2016 (31)
  • 2015 (32)
  • 2014 (25)
  • 2013 (50)
  • 2012 (18)
  • 2011 (69)

Subject

  • Drug Trafficking (76)
  • Take Back Day (25)
  • Fake Pills (22)
  • Guns/Weapons (12)
  • Outreach/Drug Prevention (10)
  • Prescription Drugs (7)
  • Synthetic drugs (7)
  • Money Laundering (6)
  • Fentanyl Awareness (5)
  • Guilty Plea (5)
  • Seizures (Drugs/Property) (5)
  • Arrests/Convictions - Major (4)
  • Diversion Division (4)
  • Overdose (4)
  • Major Law Enforcement Operation (3)
  • OCDETF/Task Force (3)
  • Pharmaceuticals/Pharmacists/Physicians (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Critical Incident (2)
  • Extraditions (2)
  • One Pill Can Kill (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Fentanyl Free America (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Press Conferences (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Terrorism (1)

Drug Name

  • Fentanyl (41)
  • Methamphetamine (37)
  • Cocaine (17)
  • Heroin (15)
  • Marijuana (Cannabis) (6)
  • Amphetamines (1)
  • LSD (1)
  • Morphine (1)
  • Oxycodone (1)
  • Psilocybin (1)
  • Synthetic Opioids (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Sede (414)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • San Diego (246)
  • Rocky Mountain (166)
  • Omaha (137)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Phoenix (274)
  • Philadelphia (140)
Clear All Results
408 Results - Showing 201 to 210
PRESS RELEASE

Over 20 People Indicted In Coraopolis Drug Operation

CORAOPOLIS, Pa. - The Special Agent in (SAC) of the Drug Enforcement Administration’s Philadelphia Division, Gary Tuggle and the Chief of the Coraopolis Police Department, Ronald Denbow announced the indictment of 22 people for violations of the Pennsylvania Controlled Substance Drug, Device and Cosmetic Act. The indictment of 17 men...
PRESS RELEASE

DEA Medical Marijuana Case Secures Indictments Against Five

PHOENIX - Special Agent in Charge Doug Coleman and Attorney General Mark Brnovich announced a State Grand Jury indictment of Perry Hester, Brandon Hester, James Donaldson, and Christopher Rafferty in connection with a statewide medical marijuana caregiver grow scheme. The defendants are accused of giving fraudulent information to the state...
PRESS RELEASE

DEA Announces 11th National Prescription Drug Take-Back Day

PHILADELPHIA - Special Agent in Charge Gary Tuggle announced today that the Drug Enforcement Administration’(DEA) Philadelphia Field Division will conduct its 11th National Prescription Drug Take-Back Day event across Pennsylvania and Delaware on April 30 between 10:00 a.m. and 2:00 p.m. As with previous Take-Back events, approximately 300 collection sites...
PRESS RELEASE

11th Drug Take-Back Announced By DEA

PHOENIX - DEA announced today that the 11th National Prescription Drug Take-Back will take place April 30th from 10 am-2 pm local time. As with the previous 10 Take-Back events, sites will be set up throughout communities nationwide so local residents can anonymously return their unwanted, unneeded, or expired prescription...
PRESS RELEASE

DEA To Sponsor Off-Script Play For Valley High School As Part Of The 360 Strategy To Address Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Division announced today that the DEA will sponsor a play entitled Off-Script for the junior and senior high school students of Valley High School as part of the DEA’s ongoing 360 Strategy to address prescription opioid...
PRESS RELEASE

DEA & FBI Host Screening Of Chasing The Dragon For Local Educators To Combat Prescription Opioid And Heroin Epidemic

PHILADELPHIA - DEA Assistant Special Agent in Charge David Cali and Federal Bureau of Investigation Special Agent in Charge William F. Sweeney hosted a screening of Chasing the Dragon: The Life on an Opiate Addict for local educators and media representatives at the William J. Green Federal Building in Philadelphia...
PRESS RELEASE

DEA To Train Philadelphia Area Law Enforcement On Heroin Overdose Investigations To Combat Epidemic Of Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement (DEA) announced today the Philadelphia area release of “Operation Trojan Horse,” which is a coordinated effort between the DEA and state and local law enforcement agencies to combat the current prescription opioid and heroin abuse epidemic. The DEA...
PRESS RELEASE

DEA To Sponsor Off-Script Play For High School Students As Part Of The 360 Strategy To Address Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that the DEA will sponsor a play entitled Off-Script for the students of Mount Pleasant High School as part of the DEA’s ongoing 360 Strategy to address prescription opioid and heroin abuse...
PRESS RELEASE

Members Of Chester Drug Trafficking Organization Convicted

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that a federal jury returned guilty verdicts against members of a violent drug trafficking organization that operated in and around Chester, Pennsylvania. The jury found Donald Womack, Sr., Paris Church, Ronell Whitehead...
PRESS RELEASE

DEA To Conduct Pharmacy Diversion Awareness Conference In Wilmington To Address The Diversion Of Prescription Opioids And Link To Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that the DEA will host a Pharmacy Diversion Awareness (PDAC) in Wilmington, Delaware as part of the DEA’s mission to address prescription opioid and heroin abuse. The diversion of pharmaceutical controlled substances...

Paginación

  • Primera página «
  • Anterior
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster